Hysbysiad gwybodaeth ymlaen llaw
Hysbysiad gwybodaeth ymlaen llaw yn unig yw hwn
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
Department of Health and Social Care
39 Victoria Street
London
SW1H 0EU
UK
Person cyswllt: Jay Bains
Ffôn: +44 02071047545
E-bost: jay.bains@dhsc.gov.uk
NUTS: UKI32
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: https://www.gov.uk/government/organisations/department-of-health-and-social-care
Cyfeiriad proffil y prynwr: https://www.gov.uk/government/organisations/department-of-health-and-social-care
I.3) Cyfathrebu
Gellir cael gwybodaeth ychwanegol o'r cyfeiriad uchod
Mae cyfathrebu electronig yn gofyn am ddefnyddio offer a dyfeisiau nad ydynt ar gael yn gyffredinol. Mae mynediad uniongyrchol anghyfgyfyngiedig a llawn i'r offer a dyfeisiau hyn yn bosibl, yn rhad ac am ddim, yn:
https://health-family.force.com/s/Welcome
I.4) Y math o awdurdod contractio
Gweinyddiaeth neu unrhyw awdurdod cenedlaethol neu ffederal arall, gan gynnwys eu his-adrannau rhanbarthol neu leol
I.5) Prif weithgaredd
Iechyd
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
HPV Self-sampling Cost Effectiveness Model
Cyfeirnod: C253383
II.1.2) Prif god CPV
73000000
II.1.3) Y math o gontract
Gwasanaethau
II.1.4) Disgrifiad byr
Cost-effectiveness model to understand the conditions under which harms will outweigh benefits for the offer of HPV self-sampling in the UK.
II.1.5) Cyfanswm gwerth amcangyfrifedig
Gwerth heb gynnwys TAW: 250 000.00 GBP
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Na
II.2) Disgrifiad
II.2.2) Cod(au) CPV ychwanegol
73210000
II.2.3) Man cyflawni
Cod NUTS:
UKI32
II.2.4) Disgrifiad o’r caffaeliad
Cost-effectiveness model to understand the conditions under which harms will outweigh benefits for the offer of HPV self-sampling in the UK.<br/>Deliverables will include the following:<br/>• Model Specifications: Development of a model to determine the conditions under which the introduction of self-sampling in the cervical screening programme provides the most benefits in terms of clinical outcomes for women and cost-effectiveness for the programme.<br/>• Cost effectiveness model: Running of model and analysis of cost-effectiveness.<br/>• Model Technical Report: Interim report(s) by Spring 2025, to feed into the ISE design process.<br/>• Model: Final report(s) in Spring 2026 clearly outlining model type, analytical approach, assumptions, uncertainties, results, and discussion, including implications to policy.<br/>• It is expected that the final paper is published in a peer-reviewed journal to highlight the high-quality and robust work required.<br/>• Transfer of the model’s outputs to the UK NSC
II.2.14) Gwybodaeth ychwanegol
1.1. For avoidance of doubt THIS IS NOT a call for competition.<br/>This is a market consultation. The purpose is to advise suppliers of the forthcoming Department of Health and Social Care (DHSC) procurement and seek feedback from potential bidders and existing providers that may inform the final specifications and/or procurement approach to the services.
II.3) Dyddiad amcangyfrifedig ar gyfer cyhoeddi’r hysbysiad contract:
01/05/2024
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Na
Section VI: Gwybodaeth ategol
VI.5) Dyddiad anfon yr hysbysiad hwn
12/03/2024